登录 | 注册
我要路演
纪要

Abbott Laboratories (ABT) Q3 2023 Earnings Call

2023-10-19 00:14

Abbott Laboratories (NYSE:ABT) Q3 2023 Earnings Call Transcript October 18, 2023 9:00 AM ET

Company Participants

Mike Comilla - Vice President, Investor Relations

Robert Ford - Chairman and Chief Executive Officer

Philip Boudreau - Senior Vice President, Finance and Chief Financial Officer

Conference Call Participants

Joshua Jennings - TD Cowen

Larry Biegelsen - Wells Fargo

Robbie Marcus - JPMorgan

Danielle Antalffy - UBS

Joanne Wuensch - Citibank

Vijay Kumar - Evercore ISI

Matt Miksic - Barclays

Jayson Bedford - Raymond James

Operator

Good morning, and thank you for standing by. Welcome to Abbott's Third Quarter 2023 Earnings Conference Call. All participants will be able to listen only until the question-and-answer portion of this call. [Operator Instructions] This call is being recorded by Abbott. With the exception of any participants questions asked during the question-and-answer session, the entire call including the question-and-answer session is material copyrighted by Abbott. It cannot be recorded or reproduced broadcast without Abbott's expressed written permission.

I would now like to introduce Mr. Mike Comilla, Vice President, Investor Relations.

Mike Comilla

Good morning, and thank you for joining us. With me today are Robert Ford, Chairman and Chief Executive Officer; Bob Funck, Executive Vice President, Finance; and Phil Boudreau, Senior Vice President, Finance and Chief Financial Officer. Robert and Phil will provide opening remarks. Following their comments, we'll take your questions.

Before we get started, some statements made today may be forward-looking for purposes of the Private Securities Litigation Reform Act of 1995, including the expected financial results for 2023. Abbott cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological, and other factors that may affect Abbott's operations are discussed in Item 1A, Risk Factors, to our annual report on Form 10-K for the year ended

雅培
雅培公司(ABT.US)2023年第三季度业绩电话会
开始时间
2023-10-19 00:14
会议性质
业绩会路演
会议形式
线上会议